Eleonora Bergo
Overview
Explore the profile of Eleonora Bergo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Padovan M, Cerretti G, Caccese M, Barbot M, Bergo E, Occhi G, et al.
Expert Rev Endocrinol Metab
. 2023 Mar;
18(2):181-198.
PMID: 36876325
Introduction: Pituitary adenomas can show a tendency to grow, despite multimodal treatment. Temozolomide (TMZ) has been used in the last 15 years in patients with aggressive pituitary tumors. TMZ requires...
2.
Chiusole B, Tortorelli I, Galiano A, Murtas F, Ahcene-Djaballah S, Tierno G, et al.
Cancers (Basel)
. 2023 Feb;
15(4).
PMID: 36831386
Incidences of soft tissue sarcomas (STS) steadily increase with age. Yet, despite the high prevalence in advanced age, older patients (pts) are underrepresented in sarcoma clinical trials and evidence-based guidelines...
3.
Procaccio L, Bergamo F, Gatti M, Chiusole B, Tierno G, Bergo E, et al.
Eur J Cancer
. 2022 Nov;
177:112-119.
PMID: 36335781
Background: Approximately 50% of colorectal cancers occur in older patients. International societies recommend geriatric tools to optimise treatment of older patients. Comprehensive Geriatric Assessment (CGA) is a multidimensional assessment used...
4.
Lombardi G, Del Bianco P, Brandes A, Eoli M, Ruda R, Ibrahim T, et al.
Eur J Cancer
. 2021 Aug;
155:179-190.
PMID: 34388515
Background: The REGOMA trial showed that regorafenib significantly improved overall survival in patients with recurrent glioblastoma compared with lomustine. Patients treated with regorafenib experienced a higher occurrence of grade 3-4...
5.
Pierantoni F, Basso U, Maruzzo M, Lamberti E, Bimbatti D, Tierno G, et al.
J Geriatr Oncol
. 2020 Sep;
12(2):290-297.
PMID: 32972885
Background: There is poor data on the prognostic role of Comprehensive Geriatric Assessment (CGA) in older patients with metastatic renal cell carcinoma (mRCC) treated with first line Tyrosine Kinase Inhibitors...
6.
Caccese M, Padovan M, dAvella D, Chioffi F, Gardiman M, Berti F, et al.
Crit Rev Oncol Hematol
. 2020 Jul;
153:103062.
PMID: 32717623
Anaplastic Astrocytoma(AA) is a malignant, diffusely infiltrating, primary brain tumor. According to the WHO 2016 classification of central-nervous-system tumors, AA has been described as a glial tumor with no co-deletion...
7.
Lombardi G, Bergo E, Caccese M, Padovan M, Bellu L, Brunello A, et al.
Cancers (Basel)
. 2019 Oct;
11(10).
PMID: 31600898
Treatment of elderly glioblastoma patients (EGP) is a challenge in neuro-oncology. The comprehensive geriatric assessment (CGA) is currently used to assess geriatric oncological patients with other types of tumors. We...
8.
Lombardi G, Caccese M, Bellu L, Pambuku A, Bergo E, Berti F, et al.
Anticancer Drugs
. 2018 Aug;
29(9):924-928.
PMID: 30080691
Glioblastoma is the most common and aggressive primitive brain tumor in adults. Temozolomide (TMZ) administered daily with radiation therapy, followed by adjuvant TMZ has become the standard treatment. Although TMZ...
9.
Lombardi G, Bergo E, Del Bianco P, Bellu L, Pambuku A, Caccese M, et al.
Am J Clin Oncol
. 2018 May;
41(12):1263-1271.
PMID: 29750673
Background: Health-related quality of life (HRQoL), cognitive function, and psychological status represent an important focus during the treatment of glioblastoma patients. Nevertheless, few randomized, prospective clinical trials have analyzed these...
10.
Muscaritoli M, Lucia S, Farcomeni A, Lorusso V, Saracino V, Barone C, et al.
Oncotarget
. 2017 Nov;
8(45):79884-79896.
PMID: 29108370
Background: In cancer patients, malnutrition is associated with treatment toxicity, complications, reduced physical functioning, and decreased survival. The Prevalence of Malnutrition in Oncology (PreMiO) study identified malnutrition or its risk...